FilingPulse

PDSB insider transaction filings

PDS Biotechnology Corp — 32 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-03-03. Screen PDSB transaction legs live →

Insider transaction summary — last 90 days

No Form 4 filings for PDSB between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.

Recent Form 4 filings — PDS Biotechnology Corp

FiledFormInsiderReported transactionsSource
2026-03-034BEDU-ADDO FRANK — President/CEO, DirectorGrant/award (A): 548,782 (derivative) @ $0EDGAR
2026-03-034CONN GREGORY — Chief Scientific OfficerGrant/award (A): 150,000 (derivative) @ $0EDGAR
2026-03-034Shepard Kirk V. — Chief Medical OfficerGrant/award (A): 300,000 (derivative) @ $0EDGAR
2026-03-034Brown Spencer D. — Senior VP, General CounselGrant/award (A): 300,000 (derivative) @ $0EDGAR
2026-03-034Toutain Stephan — Chief Operating OfficerGrant/award (A): 300,000 (derivative) @ $0EDGAR
2026-03-034Freitag Gregory Gene — DirectorGrant/award (A): 54,876 (derivative) @ $0EDGAR
2026-03-034Iliev Ilian — DirectorGrant/award (A): 54,876 (derivative) @ $0EDGAR
2026-03-034Ali-Jackson Kamil — DirectorGrant/award (A): 54,876 (derivative) @ $0EDGAR
2026-03-034Boesgaard Lars — Chief Financial OfficerGrant/award (A): 300,000 (derivative) @ $0EDGAR
2026-03-034Glover Stephen C. — DirectorGrant/award (A): 54,876 (derivative) @ $0EDGAR
2026-03-034BRAWLEY OTIS W — DirectorGrant/award (A): 54,876 (derivative) @ $0EDGAR
2025-07-254BEDU-ADDO FRANK — President/CEO, DirectorGrant/award (A): 300,000 (derivative) @ $0 · Grant/award (A): 150,000 (derivative) @ $0EDGAR
2025-07-254Shepard Kirk V. — Chief Medical OfficerGrant/award (A): 150,000 (derivative) @ $0EDGAR
2025-07-254Brown Spencer D. — Senior VP, General CounselGrant/award (A): 56,000 (derivative) @ $0 · Grant/award (A): 150,000 (derivative) @ $0EDGAR
2025-07-254CONN GREGORY — Chief Scientific OfficerGrant/award (A): 46,648 (derivative) @ $0 · Grant/award (A): 40,000 (derivative) @ $0EDGAR
2025-07-254Toutain Stephan — Chief Operations OfficerGrant/award (A): 150,000 (derivative) @ $0EDGAR
2025-07-254Boesgaard Lars — Chief Financial OfficerGrant/award (A): 150,000 (derivative) @ $0EDGAR
2025-06-114Iliev Ilian — DirectorGrant/award (A): 22,700 (derivative) @ $0EDGAR
2025-06-114Ali-Jackson Kamil — DirectorGrant/award (A): 22,700 (derivative) @ $0EDGAR
2025-06-114Freitag Gregory Gene — DirectorGrant/award (A): 22,700 (derivative) @ $0EDGAR
2025-06-114Glover Stephen C. — DirectorGrant/award (A): 22,700 (derivative) @ $0EDGAR
2025-06-114BRAWLEY OTIS W — DirectorGrant/award (A): 22,700 (derivative) @ $0EDGAR
2025-03-034Freitag Gregory Gene — DirectorPurchase (P): 15,060 @ $1.66 · Purchase (P): 15,060 (derivative)EDGAR
2025-03-034Glover Stephen C. — DirectorPurchase (P): 15,061 @ $1.66 · Purchase (P): 15,061 (derivative)EDGAR
2024-06-254Freitag Gregory Gene — DirectorGrant/award (A): 9,000 (derivative) @ $0EDGAR
2024-06-254Iliev Ilian — DirectorGrant/award (A): 9,000 (derivative) @ $0EDGAR
2024-06-254Ali-Jackson Kamil — DirectorGrant/award (A): 9,000 (derivative) @ $0EDGAR
2024-06-254SYKES RICHARD — DirectorGrant/award (A): 9,000 (derivative) @ $0EDGAR
2024-06-254Glover Stephen C. — DirectorGrant/award (A): 9,000 (derivative) @ $0EDGAR
2024-06-254BRAWLEY OTIS W — DirectorGrant/award (A): 9,000 (derivative) @ $0EDGAR
2024-05-024Toutain Stephan — Chief Operations OfficerGrant/award (A): 200,000 (derivative) @ $0EDGAR
2024-01-234Shepard Kirk V. — Chief Medical OfficerGrant/award (A): 200,000 (derivative) @ $0EDGAR

Recent 8-K events — PDS Biotechnology Corp

FiledFormItems reportedSource
2026-09-228-K8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2026-09-218-K8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2026-09-148-K1.02 — Termination of a Material Definitive Agreement
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2026-09-088-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits		EDGAR
2026-09-048-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
9.01 — Financial Statements and Exhibits		EDGAR
2026-08-258-K?
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers		EDGAR
2026-08-198-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-08-148-K5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits		EDGAR
2026-08-138-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2026-08-118-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits		EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=PDSB returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →